5a14: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
==Human CDK2 with type II inhibitor==
==Human CDK2 with type II inhibitor==
<StructureSection load='5a14' size='340' side='right' caption='[[5a14]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
<StructureSection load='5a14' size='340' side='right'caption='[[5a14]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[5a14]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5A14 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5A14 FirstGlance]. <br>
<table><tr><td colspan='2'>[[5a14]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5A14 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5A14 FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=LQ5:1-[4-(2-AZANYLPYRIMIDIN-4-YL)OXYPHENYL]-3-[4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL]UREA'>LQ5</scene></td></tr>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=LQ5:1-[4-(2-AZANYLPYRIMIDIN-4-YL)OXYPHENYL]-3-[4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL]UREA'>LQ5</scene></td></tr>
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene></td></tr>
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5a14 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5a14 OCA], [http://pdbe.org/5a14 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5a14 RCSB], [http://www.ebi.ac.uk/pdbsum/5a14 PDBsum]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5a14 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5a14 OCA], [http://pdbe.org/5a14 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5a14 RCSB], [http://www.ebi.ac.uk/pdbsum/5a14 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5a14 ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
Line 18: Line 19:
</div>
</div>
<div class="pdbe-citations 5a14" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 5a14" style="background-color:#fffaf0;"></div>
==See Also==
*[[Cyclin-dependent kinase 3D structures|Cyclin-dependent kinase 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Large Structures]]
[[Category: Alexander, L T]]
[[Category: Alexander, L T]]
[[Category: Bountra, C]]
[[Category: Bountra, C]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA